Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies-Reference-Cited by-同舟云学术

Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies

Published:2017-07-27 Issue:3 Volume:44 Page:603-619
ISSN:0586-7614
Container-title:Schizophrenia Bulletin
language:en
Short-container-title:

Author:

Kishimoto Taishiro¹²³⁴,Hagi Katsuhiko²⁵,Nitta Masahiro²⁵,Leucht Stefan⁶,Olfson Mark⁷,Kane John M²³⁴⁸,Correll Christoph U²³⁴⁸

Affiliation:

1. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan

2. Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY

3. Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, NY

4. Center of Psychiatric Neuroscience, The Feinstein Institute for Medical Research, Manhasset, NY

5. Sumitomo Dainippon Pharma Co., Ltd., Medical Affairs, Tokyo, Japan

6. Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universität München, München, Germany

7. New York State Psychiatric Institute/Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY

8. Department of Psychiatry and Behavioral Medicine, Albert Einstein College of Medicine, Bronx, NY

Funder

The Zucker Hillside Hospital Advanced Center for Interventions and Services Research for the Study of Schizophrenia

National Institute of Mental Health

Publisher

Oxford University Press (OUP)

Subject

Psychiatry and Mental health

Link

http://academic.oup.com/schizophreniabulletin/article-pdf/44/3/603/24566163/sbx090.pdf

Reference74 articles.

1. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches;Lieberman;Biol Psychiatry,2001

2. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study;van Haren;Neuropsychopharmacology,2007

3. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder;Robinson;Arch Gen Psychiatry,1999

4. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials;Leucht;Am J Psychiatry,2003

5. How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials;Leucht;Mol Psychiatry,2009

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations between antipsychotics exposure and dementia risk: A prospective cohort study of 415,100 participants;Journal of Affective Disorders;2024-03

2. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series;Journal of Child and Adolescent Psychopharmacology;2023-12-01

3. Out-of-Pocket Costs for Long-Acting Injectable and Oral Antipsychotics Among Medicare Patients With Schizophrenia;Psychiatric Services;2023-11-14

4. Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study;International Clinical Psychopharmacology;2023-11-02

5. Response prediction in treatment of patients with schizophrenia after switching from oral aripiprazole to aripiprazole once-monthly;Schizophrenia Research;2023-10